142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

4304.0
Tobacco Use and Treatment in the Oncology Setting (A Collaborative Session with the Cancer Forum and Alcohol, Tobacco, and Other Drugs Section)

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Tuesday, November 18, 2014: 2:30 PM - 4:00 PM
Oral
Quitting smoking and staying smokefree is of utmost importance for cancer survivors. Toward this end, this session will focus on a discussion of tobacco treatment issues among bladder cancer survivors. The session will also focus on the role that cancer centers can play in promoting multi-level tobacco control plans and the potential of lung cancer screening programs as an opportunity for providing tobacco use treatment. The content of the session will be geared towards researchers, public health professionals, and clinicians working in the area of tobacco control and cancer prevention.
Session Objectives: Describe methods to improve tobacco knowledge and promote tobacco cessation among bladder cancer survivors. Discuss how cancer centers can leverage resources to develop a tobacco control plan at the institutional, local, state, and national/international levels. Identify the importance of provider involvement in assisting bladder cancer patients to quit smoking. Examine issues related to lung cancer screening sites as a setting for providing tobacco use treatment.
Moderator:
Vani Simmons, Ph.D.

2:30pm
Predictors of Knowledge of the Harmfulness of Tobacco Use in Bladder Cancer Survivors
Sarah Connor, MPH, CHES, Jeffrey Bassett, MD, John Gore, MD, MS, Lorna Kwan, MPH, Josemanuel Saucedo, Christopher Saigal, MD, MPH and William McCarthy, PhD
2:50pm
Smoking cessation at bladder cancer diagnosis: Many patients might benefit from this teachable moment
Josemanuel Saucedo, Jeffrey Bassett, MD, John Gore, MD, MS, Lorna Kwan, MPH, Sarah Connor, MPH, CHES, Christopher Saigal, MD, MPH and William McCarthy, PhD
3:10pm
EndTobacco - A Program Linking the WHO MPOWER Framework with the CDC Best Practices for Evidence-based Tobacco Control at Institutional, Local and National Levels
Ernest Hawk, MD, MPH, Jennifer Tektiridis, PhD, David W. Wetter, PhD, Lewis Foxhall, MD, Jo Ann Ward, MPH, Mark Moreno and Martha Salas

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Cancer Forum
Endorsed by: Public Health Nursing, Alcohol, Tobacco, and Other Drugs

See more of: Cancer Forum